https://td2inc.com/resources TD2 Resources en Thu, 26 Mar 2026 17:48:14 GMT 2026-03-26T17:48:14Z en https://td2inc.com/resources/how-td2-is-strengthening-site-collaboration-through-data-and-shared-kpis <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/how-td2-is-strengthening-site-collaboration-through-data-and-shared-kpis" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/kpis.png" alt="How TD2 is Strengthening Site Collaboration Through Data and Shared KPIS" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/how-td2-is-strengthening-site-collaboration-through-data-and-shared-kpis" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/kpis.png" alt="How TD2 is Strengthening Site Collaboration Through Data and Shared KPIS" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=22578525&amp;k=14&amp;r=https%3A%2F%2Ftd2inc.com%2Fresources%2Fhow-td2-is-strengthening-site-collaboration-through-data-and-shared-kpis&amp;bu=https%253A%252F%252Ftd2inc.com%252Fresources&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Clinical Thu, 26 Mar 2026 17:48:14 GMT admin@td2inc.com (TD2 Admin) https://td2inc.com/resources/how-td2-is-strengthening-site-collaboration-through-data-and-shared-kpis 2026-03-26T17:48:14Z https://td2inc.com/resources/development-of-a-receptor-occupancy-assay-for-a-therapeutic-bi-specific-antibody <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/development-of-a-receptor-occupancy-assay-for-a-therapeutic-bi-specific-antibody" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/poster-219-thumb-2.jpg" alt="Development of a Receptor Occupancy Assay for a Therapeutic Bi-Specific Antibody" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/development-of-a-receptor-occupancy-assay-for-a-therapeutic-bi-specific-antibody" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/poster-219-thumb-2.jpg" alt="Development of a Receptor Occupancy Assay for a Therapeutic Bi-Specific Antibody" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=22578525&amp;k=14&amp;r=https%3A%2F%2Ftd2inc.com%2Fresources%2Fdevelopment-of-a-receptor-occupancy-assay-for-a-therapeutic-bi-specific-antibody&amp;bu=https%253A%252F%252Ftd2inc.com%252Fresources&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Flow Tue, 10 Feb 2026 18:13:52 GMT admin@td2inc.com (TD2 Admin) https://td2inc.com/resources/development-of-a-receptor-occupancy-assay-for-a-therapeutic-bi-specific-antibody 2026-02-10T18:13:52Z https://td2inc.com/resources/webinar-the-future-of-advanced-receptor-mediated-therapies <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/webinar-the-future-of-advanced-receptor-mediated-therapies" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/receptor-mediated-webinar.png" alt="Webinar: The Future of Advanced Receptor-Mediated Therapies: Translating Mechanism to Clinical Impact" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/webinar-the-future-of-advanced-receptor-mediated-therapies" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/receptor-mediated-webinar.png" alt="Webinar: The Future of Advanced Receptor-Mediated Therapies: Translating Mechanism to Clinical Impact" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=22578525&amp;k=14&amp;r=https%3A%2F%2Ftd2inc.com%2Fresources%2Fwebinar-the-future-of-advanced-receptor-mediated-therapies&amp;bu=https%253A%252F%252Ftd2inc.com%252Fresources&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Clinical Tue, 16 Dec 2025 17:26:05 GMT admin@td2inc.com (TD2 Admin) https://td2inc.com/resources/webinar-the-future-of-advanced-receptor-mediated-therapies 2025-12-16T17:26:05Z https://td2inc.com/resources/streamlining-clinical-trial-start-ups <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/streamlining-clinical-trial-start-ups" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/video-thumb-clinical-trial.png" alt="Webinar: Streamlining Clinical Trial Start-Ups: A Data-Driven Approach" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/streamlining-clinical-trial-start-ups" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/video-thumb-clinical-trial.png" alt="Webinar: Streamlining Clinical Trial Start-Ups: A Data-Driven Approach" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=22578525&amp;k=14&amp;r=https%3A%2F%2Ftd2inc.com%2Fresources%2Fstreamlining-clinical-trial-start-ups&amp;bu=https%253A%252F%252Ftd2inc.com%252Fresources&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Regulatory Tue, 16 Dec 2025 17:16:33 GMT admin@td2inc.com (TD2 Admin) https://td2inc.com/resources/streamlining-clinical-trial-start-ups 2025-12-16T17:16:33Z https://td2inc.com/resources/podcast-steve-gately-joins-bourne-partners-for-a-deep-dive-on-the-future-of-oncology-cros <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/podcast-steve-gately-joins-bourne-partners-for-a-deep-dive-on-the-future-of-oncology-cros" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/deep-dive-cro-landscape.png" alt="Podcast: Steve Gately Joins Bourne Partners for a Deep Dive on the Future of Oncology CROs" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/podcast-steve-gately-joins-bourne-partners-for-a-deep-dive-on-the-future-of-oncology-cros" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/deep-dive-cro-landscape.png" alt="Podcast: Steve Gately Joins Bourne Partners for a Deep Dive on the Future of Oncology CROs" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=22578525&amp;k=14&amp;r=https%3A%2F%2Ftd2inc.com%2Fresources%2Fpodcast-steve-gately-joins-bourne-partners-for-a-deep-dive-on-the-future-of-oncology-cros&amp;bu=https%253A%252F%252Ftd2inc.com%252Fresources&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Clinical Tue, 16 Dec 2025 16:56:18 GMT admin@td2inc.com (TD2 Admin) https://td2inc.com/resources/podcast-steve-gately-joins-bourne-partners-for-a-deep-dive-on-the-future-of-oncology-cros 2025-12-16T16:56:18Z https://td2inc.com/resources/webinar-fih-clinical-trial-planning-for-radiopharmaceuticals-from-ind-to-patient-dosing <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/webinar-fih-clinical-trial-planning-for-radiopharmaceuticals-from-ind-to-patient-dosing" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/Webinar%20Hero%20Image.png" alt="Webinar: FIH Clinical Trial Planning for Radiopharmaceuticals: From IND to Patient Dosing" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/webinar-fih-clinical-trial-planning-for-radiopharmaceuticals-from-ind-to-patient-dosing" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/Webinar%20Hero%20Image.png" alt="Webinar: FIH Clinical Trial Planning for Radiopharmaceuticals: From IND to Patient Dosing" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=22578525&amp;k=14&amp;r=https%3A%2F%2Ftd2inc.com%2Fresources%2Fwebinar-fih-clinical-trial-planning-for-radiopharmaceuticals-from-ind-to-patient-dosing&amp;bu=https%253A%252F%252Ftd2inc.com%252Fresources&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Clinical Tue, 29 Jul 2025 16:09:17 GMT admin@td2inc.com (TD2 Admin) https://td2inc.com/resources/webinar-fih-clinical-trial-planning-for-radiopharmaceuticals-from-ind-to-patient-dosing 2025-07-29T16:09:17Z https://td2inc.com/resources/poster-advancing-precision-oncology <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/poster-advancing-precision-oncology" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/poster-thumb-1273.jpg" alt="Advancing Precision Oncology: Development and Utilization of Breast Cancer PDX Models for In Vivo Drug Discovery" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/poster-advancing-precision-oncology" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/poster-thumb-1273.jpg" alt="Advancing Precision Oncology: Development and Utilization of Breast Cancer PDX Models for In Vivo Drug Discovery" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=22578525&amp;k=14&amp;r=https%3A%2F%2Ftd2inc.com%2Fresources%2Fposter-advancing-precision-oncology&amp;bu=https%253A%252F%252Ftd2inc.com%252Fresources&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Sat, 26 Apr 2025 12:20:40 GMT admin@td2inc.com (TD2 Admin) https://td2inc.com/resources/poster-advancing-precision-oncology 2025-04-26T12:20:40Z https://td2inc.com/resources/poster-measurement-of-basophil-activation-using-a-flow-cytometry-method <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/poster-measurement-of-basophil-activation-using-a-flow-cytometry-method" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/poster-measurement-of-basophil-activation.jpg" alt="Measurement of Basophil Activation Using a Flow Cytometry Method for Applications in Clinical Research and Clinical Trials" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/poster-measurement-of-basophil-activation-using-a-flow-cytometry-method" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/poster-measurement-of-basophil-activation.jpg" alt="Measurement of Basophil Activation Using a Flow Cytometry Method for Applications in Clinical Research and Clinical Trials" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=22578525&amp;k=14&amp;r=https%3A%2F%2Ftd2inc.com%2Fresources%2Fposter-measurement-of-basophil-activation-using-a-flow-cytometry-method&amp;bu=https%253A%252F%252Ftd2inc.com%252Fresources&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Flow Sat, 26 Apr 2025 12:17:32 GMT admin@td2inc.com (TD2 Admin) https://td2inc.com/resources/poster-measurement-of-basophil-activation-using-a-flow-cytometry-method 2025-04-26T12:17:32Z https://td2inc.com/resources/ind-readiness <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/ind-readiness" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/shutterstock_267243104.jpg" alt="IND Readiness: Your Roadmap to a Successful IND Submission" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/ind-readiness" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/shutterstock_267243104.jpg" alt="IND Readiness: Your Roadmap to a Successful IND Submission" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=22578525&amp;k=14&amp;r=https%3A%2F%2Ftd2inc.com%2Fresources%2Find-readiness&amp;bu=https%253A%252F%252Ftd2inc.com%252Fresources&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Regulatory Thu, 27 Feb 2025 18:47:14 GMT admin@td2inc.com (TD2 Admin) https://td2inc.com/resources/ind-readiness 2025-02-27T18:47:14Z https://td2inc.com/resources/optimizing-specimen-stability-a-comparative-analysis-of-shipping-protocols <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/optimizing-specimen-stability-a-comparative-analysis-of-shipping-protocols" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/white-paper-optimizing-specimen-stability-thumb.png" alt="Navigating Project Optimus with TD2 - TD2 Precision Oncology" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="https://td2inc.com/resources/optimizing-specimen-stability-a-comparative-analysis-of-shipping-protocols" title="" class="hs-featured-image-link"> <img src="https://td2inc.com/hubfs/white-paper-optimizing-specimen-stability-thumb.png" alt="Navigating Project Optimus with TD2 - TD2 Precision Oncology" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=22578525&amp;k=14&amp;r=https%3A%2F%2Ftd2inc.com%2Fresources%2Foptimizing-specimen-stability-a-comparative-analysis-of-shipping-protocols&amp;bu=https%253A%252F%252Ftd2inc.com%252Fresources&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Flow Mon, 06 Jan 2025 17:37:49 GMT admin@td2inc.com (TD2 Admin) https://td2inc.com/resources/optimizing-specimen-stability-a-comparative-analysis-of-shipping-protocols 2025-01-06T17:37:49Z